Efficacy and safety of a four-week treatment with budesonide/formoterol in patients with cough variant asthma: Open-label, randomized and parallel-group study compared with budesonide.
Phase of Trial: Phase III
Latest Information Update: 08 Apr 2013
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- 31 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 17 Apr 2012 Additional lead trial investigator (Hisako Matsumoto) identified as reported by University Hospital Medical Information Network - Japan.
- 19 Feb 2011 New trial record